Emergent Product Development Gaithersburg, Inc. Company Profile
✉ Email this page to a colleague
Biologic Drugs for Emergent Product Development Gaithersburg, Inc.
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Emergent Product Development Gaithersburg, Inc. | CYFENDUS | anthrax vaccine adsorbed, adjuvanted | Injection | 125761 | 10,357,559 | 2034-12-23 | DrugPatentWatch analysis and company disclosures |
| Emergent Product Development Gaithersburg, Inc. | CYFENDUS | anthrax vaccine adsorbed, adjuvanted | Injection | 125761 | 10,456,463 | 2031-05-27 | DrugPatentWatch analysis and company disclosures |
| Emergent Product Development Gaithersburg, Inc. | CYFENDUS | anthrax vaccine adsorbed, adjuvanted | Injection | 125761 | 6,207,646 | 2016-10-30 | DrugPatentWatch analysis and company disclosures |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
Similar Applicant Names
This search can help find similar names.
